Patent · US Active

Compositions and methods for the treatment of Zellweger spectrum disorder

US11065247B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Inventors

Joseph Hacia · Los Angeles, US
Nancy E. Braverman · Los Angeles, US
Patricia Dranchak · Gaithersburg, US
James Inglese

Key dates

Filing date	May 20, 2019
Grant date	Jul 20, 2021
Priority date	—
Expiry date	May 20, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods of treating Zellweger spectrum disorder (ZSD) in a subject in need thereof or improving peroxisome assembly in a cell in need thereof comprising administering to the subject a therapeutically effective amount of Compounds of Formula I or II.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.